The reduction in revenue of Annovera and Imvexxy was greater than than the increase in Nextellis in 2nd half v 1st half 23/24 . Therefore contraceptive sales and profits combined actually reduced. The sales reps are just replacing one of our products with another. We paid a small fortune for the distribution rights to both these products. Nearly all products sold today are have their distribution controlled or owned by the manufacturer. The days of importers ; distributors;wholesalers and retailers are long gone. Too many fingers in the pie. It is all about price. This company I am certain the leaders are all knowing of this. Yet they spruik their bulls$%#t diatribe about cycles and show graphs on the incline. They treat holders like dumb idiots. Which we have been. Teach them a lesson. Vote with Common sense not whacky nonsense. The management of this company have been taking the shareholders for ride for the past decade.
MYX Price at posting:
$4.55 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)